Marinus Pharma (MRNS) – Litigation
-
Marinus Pharma (MRNS) Comments on Patent Challenge by Ovid, Provides Update on Marinus’ Post Grant Review
-
Marinus Pharma (MRNS) Announces New Method of Use Patent Granted for IV Ganaxolone by USPTO in Status Epilepticus
Back to MRNS Stock Lookup